Nootropic compound index
Every nootropic in our data with its class, goals, onset and duration, half-life, monthly cost and safety rating. Filter by goal or class, sort by name, discussion rank, cost or onset, and open a row for mechanism, studies, dosing and safety.
Sort
Goal
2 of 40 compounds, class Other, A to Z
How to read the table
Onset, duration on a 24-hour axis. The pale part runs from the dose to the onset, the solid part for the listed duration.
Safety is a 1 to 5 score stored with each compound, 5 the safest. How each score was set is not recorded, so read it as an editorial summary, not a clinical grade.
| # | Compound | Goals | Onset, duration | Half-life | Cost / mo | Safety |
|---|---|---|---|---|---|---|
| 01 | ExenatideGLP-1 agonist | Weight management, Neuroprotection, Metabolic health | 30 min, 6 h | 2.4 h | not listed | |
| 02 | Methylene BlueElectron carrier | Energy, Memory, Longevity, Focus | 30 min, 8 h | 6 h | $15 |
Popular follows the discussion rank stored with each compound. Where the rank came from is not recorded. The 10 compounds without a rank come last.
Goals come from each compound's goal tags, all shown in the Goals column. Calm counts anxiety and stress tags, Motivation counts motivation and dopamine, Memory counts memory and neuroplasticity, Neuroprotection counts neuroprotection and longevity.
Cost is an estimated monthly cost from our data. 10 compounds have no estimate and sort last on cost.
Onset and duration are listed for 38 of 40 compounds. Compounds without them sort last on onset.
The research benches grade the human evidence compound by compound. Open the benches